Compared with nonusers, adults taking GLP-1s had a: 17 percent lower risk of venous thromboembolism, or blood clots in the veins 31 percent lower risk of pulmonary embolism, a potentially life-threatening clot that travels to the lungs 21 percent lower risk of going to the emergency department 44 percent lower risk of all-cause mortality (death from any cause) Researchers also observed lower stroke rates among GLP-1 users, although this difference didnt reach statistical significance
Use in patients undergoing obesity-related weight loss treatment , including GLP-1 receptor agonists, dual agonists targeting GLP-1, GIP, and/or glucagon pathways, and triple agonists targeting GLP-1, GIP, and glucagon pathways
If you are taking an approved GLP-1 receptor agonist and are planning a pregnancy, discuss this with your GP or specialist well in advance to allow adequate time to safely discontinue the medication before conception, in line with the product-specific guidance in the relevant SmPC
The timeline is actually quite efficientyou're seeing clinically meaningful results month by month with a well-tolerated medication rather than battling constant hunger as in traditional calorie restriction
:max_bytes(150000):strip_icc()/benefits-of-glutathione-89457_final-01-502464fe91b2444285b0cccf8cb0a33c.png)
